iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
84.27
-0.24 (-0.28%)
Dec 17, 2025, 3:12 PM EST - Market open
IHE Holdings Information
IHE is an equity ETF with a total of 48 individual holdings. The top holdings are Eli Lilly and Company stock at 25.62%, Johnson & Johnson at 22.64%, Merck & Co. at 4.45%, Viatris at 4.28%, and Bristol-Myers Squibb Company at 4.18%.
Total Holdings
25
Top 10 Percentage
78.65%
Asset Class
Equity
ETF Category
Health
Assets
839.27M
PE Ratio
22.54
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 25.62% |
| 2 | JNJ | Johnson & Johnson | 22.64% |
| 3 | MRK | Merck & Co., Inc. | 4.45% |
| 4 | VTRS | Viatris Inc. | 4.28% |
| 5 | BMY | Bristol-Myers Squibb Company | 4.18% |
| 6 | RPRX | Royalty Pharma plc | 3.99% |
| 7 | PFE | Pfizer Inc. | 3.96% |
| 8 | ELAN | Elanco Animal Health Incorporated | 3.33% |
| 9 | JAZZ | Jazz Pharmaceuticals plc | 3.20% |
| 10 | ZTS | Zoetis Inc. | 2.99% |
| 11 | CORT | Corcept Therapeutics Incorporated | 2.60% |
| 12 | AXSM | Axsome Therapeutics, Inc. | 1.96% |
| 13 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.50% |
| 14 | LGND | Ligand Pharmaceuticals Incorporated | 1.17% |
| 15 | TARS | Tarsus Pharmaceuticals, Inc. | 1.00% |
| 16 | PBH | Prestige Consumer Healthcare Inc. | 0.95% |
| 17 | SUPN | Supernus Pharmaceuticals, Inc. | 0.83% |
| 18 | OCUL | Ocular Therapeutix, Inc. | 0.78% |
| 19 | LQDA | Liquidia Corporation | 0.71% |
| 20 | AVDL | Avadel Pharmaceuticals plc | 0.65% |
| 21 | AMRX | Amneal Pharmaceuticals, Inc. | 0.65% |
| 22 | WVE | Wave Life Sciences Ltd. | 0.64% |
| 23 | NUVB | Nuvation Bio Inc. | 0.64% |
| 24 | OGN | Organon & Co. | 0.59% |
| 25 | PRGO | Perrigo Company plc | 0.57% |
As of Dec 12, 2025